|Day Low/High||37.67 / 39.41|
|52 Wk Low/High||33.43 / 62.75|
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Zogenix, Inc.
NEW YORK, May 2, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Zogenix, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zogenix, Inc.
NEW YORK, April 22, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zogenix, Inc.
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zogenix, Inc.
Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of Zogenix, Inc.
NEW YORK, April 17, 2019 /PRNewswire/ -- Anadarko Petroleum Corporation (APC) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of Anadarko to Chevron Corporation.
SAN FRANCISCO, April 16, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Zogenix, Inc.
Federman & Sherwood announces that on April 12, 2019, a class action lawsuit was filed in the United States District Court for the Northern District of California against Zogenix, Inc.
SAN FRANCISCO, April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc.
NEW YORK, April 15, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.
SAN DIEGO, April 13, 2019 /PRNewswire/ -- Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq.
Risk and reward are the yin and yang of investing, and are closely related, especially in the pharmaceutical field.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Zogenix, Inc.
The way I do that is by using buy-write option strategies.
NEW YORK, April 9, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zogenix, Inc.
Shares of Zogenix plunge after the FDA rejects an initial marketing application for one of its more promising epilepsy treatment drugs.
Valuation and all the other issues that are being discussed are secondary to the price action.
The potential for a negative reaction to the Trump, Xi meeting is high.
If you are interested in Square longer term be patient and wait for the drama to end.
Tyson Foods is in the headlines today after it appointed a new CEO.
AMD clearly has momentum and that always creates strong underlying support.
After recent weakness in the biotech sector, here are some names to start watching.
Go on the offensive rather than turn defensive and miss the opportunities that are developing.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.